These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1948739)

  • 1. [The function of the vascular endothelium in glomerulonephritis and amyloidosis].
    Kozlovskaia LV; Poliantseva LR; Mukhin NA; Karryeva BCh; Maksimov NA
    Ter Arkh; 1991; 63(6):31-3. PubMed ID: 1948739
    [No Abstract]   [Full Text] [Related]  

  • 2. Endothelial cell haemostatic function after heart transplantation.
    Hunt BJ; Segal H; Yacoub M
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1182-3. PubMed ID: 1899155
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of a protein loading test on the fibrinolytic system in patients with chronic glomerulonephritis and amyloidosis].
    Poliantseva LR; Bumblite ID; Andreenko GV; Podorol'skaia LV; Zverev KV
    Ter Arkh; 1992; 64(6):19-21. PubMed ID: 1440329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous angioplasty, endothelial markers, and fibrin turnover.
    Woodburn KR; Lowe GD; Pollock JG; Rumley A; Reid AW
    J Endovasc Surg; 1994 Sep; 1():53-60. PubMed ID: 9234105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clearance of serum proteins in patients with various forms of renal diseases].
    Ado MA; Shovskaia TN; Makarenko II; Rukasuev VS
    Ter Arkh; 1977; 49(7):90-3. PubMed ID: 898085
    [No Abstract]   [Full Text] [Related]  

  • 6. Advanced glycation end-product peptides are associated with impaired renal function, but not with biochemical markers of endothelial dysfunction and inflammation, in non-diabetic individuals.
    Stam F; Schalkwijk CG; van Guldener C; ter Wee PM; Stehouwer CD
    Nephrol Dial Transplant; 2006 Mar; 21(3):677-82. PubMed ID: 16330467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical implication of urine test for markers of endothelial dysfunction and angiogenesis factors in assessment of tubulointerstitial fibrosis in chronic glomerulonephritis].
    Bobkova IN; Kozlovskaia LV; Rameeva AS; Varshavskiĭ VA; Golitsyna EP
    Ter Arkh; 2007; 79(6):10-5. PubMed ID: 17684960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lipiduria in the nephrotic syndrome].
    Neverov NI; Nikitina EA
    Ter Arkh; 1992; 64(6):16-8. PubMed ID: 1440328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiamphenicol excretion in subjects with renal insufficiency.
    Azzollini F; Gazzaniga A; Lodola E
    Int Z Klin Pharmakol Ther Toxikol; 1970 Oct; 4(4):303-8. PubMed ID: 5494879
    [No Abstract]   [Full Text] [Related]  

  • 10. Thiamphenicol excretion in subjects with renal insufficiency.
    Azzollini F; Gazzaniga A; Lodola E
    Int Z Klin Pharmakol Ther Toxikol; 1970 Oct; 3(4):303-8. PubMed ID: 5481994
    [No Abstract]   [Full Text] [Related]  

  • 11. [Disordered calcium and magnesium homeostasis in chronic renal insufficiency in chronic glomerulonephritis, pyelonephritis and renal amyloidosis].
    Barsegian BA
    Zh Eksp Klin Med; 1979; 19(3):108-12. PubMed ID: 494880
    [No Abstract]   [Full Text] [Related]  

  • 12. Blood fibrinolysis and the response to desmopressin in glomerulonephritis.
    Brommer EJ; Van den Wall Bake AW; Dooijewaard G; van Loon BJ; Emeis JJ; Weening JJ
    Thromb Haemost; 1994 Jan; 71(1):19-25. PubMed ID: 8165642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial dysfuntion in children with idiopathic nephrotic syndrome.
    Sharma B; Saha A; Dubey NK; Kapoor K; Anubhuti ; Batra VV; Upadhayay AD
    Atherosclerosis; 2014 Apr; 233(2):704-706. PubMed ID: 24583419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood volumes in patients with chronic glomerulonephritis].
    Diadyk AI; Siniachenko OV; Bagriĭ AE; Iarovaia NF; Shchukina EV
    Ter Arkh; 1992; 64(12):94-6. PubMed ID: 1292145
    [No Abstract]   [Full Text] [Related]  

  • 15. [The levels of antigens to plasminogen activators compared to their functional activity and inhibitor activity in patients with glomerulonephritis and amyloidosis].
    Bumblite ID; Poliantseva LR; Mukhin NA; Andreenko GV; Podorol'skaia LV; Liaginskiĭ AV; Varlamova NV
    Ter Arkh; 1992; 64(11):52-6. PubMed ID: 1293845
    [No Abstract]   [Full Text] [Related]  

  • 16. [Blood serum hexosamines in amyloidosis of the kidney and chronic glomerulonephritis].
    Ado MA; Mukhin NA; Staroseltseva LK
    Urol Nefrol (Mosk); 1972; 37(2):13-5. PubMed ID: 5020553
    [No Abstract]   [Full Text] [Related]  

  • 17. [Activators and inhibitors of fibrinolysis in chronic glomerulonephritis and amyloidosis].
    Podorol'skaia LV; Andreenko GV; Poliantseva LR; Bumblite ID
    Vopr Med Khim; 1996; 42(4):322-7. PubMed ID: 9254520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vascular resistance in the nephrotic syndrome].
    Wiktor Z; Jacyszyn K; Kornaszewski W; Klimkiewicz E
    Pol Arch Med Wewn; 1967; 38(5):646-52. PubMed ID: 6056416
    [No Abstract]   [Full Text] [Related]  

  • 19. [Fibrinolytic activity of the urine during chronic glomerulonephritis and amyloidosis].
    Podorol'skaia LV; Andreenko GV; Poliantseva LR; Bumblite ID
    Vopr Med Khim; 1999; 45(2):158-64. PubMed ID: 10378306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum complement in human kidney diseases].
    Lagrue G; Bariéty J; Halpern B; Milliez P
    Pathol Biol; 1967 Apr; 15(7):378-83. PubMed ID: 4864895
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.